--2024/Q4-- / 3.900M--
--2024/Q3-- / 3.583M--
Aug 14, 20242024/Q22.208M / 3.500M--
--2024/Q12.482M / 3.867M--
--2023/Q43.779M / 5.133M--
US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.3844
- +0.0444+13.06%
Trading Aug 26 10:00 ET
8.46MMarket Cap-25P/E (TTM)
0.4600High0.3800Low64.86MVolume0.4369Open0.3400Pre Close26.75MTurnover294.78%Turnover RatioLossP/E (Static)22.00MShares30.400052wk High0.20P/B8.46MFloat Cap0.325952wk Low--Dividend TTM22.00MShs Float263679868.1600Historical High--Div YieldTTM23.53%Amplitude0.3250Historical Low0.4120Avg Price1Lot Size
Tonix Pharmaceuticals Key Stats
Tonix Pharmaceuticals Q2 2024 Earnings Date
Currency：USDAug 14, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.50M | 2.21M | -1.29M |
| Miss Est. | -- | -- | -36.91% |
| EPS | -3.27 | -19.28 | -16.01 |
| Miss Est. | +96.18% | +60.84% | -489.03% |
Analyst Rating
Aug 26, 2024
Tonix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Tonix Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
